ERA Test in IVF — What Is It and Who Needs It?

Most IVF cycles fail at the implantation stage — the embryo does not attach, and the reason is not always the embryo. In some cases, the uterine lining is simply not receptive at the time of transfer. The ERA test identifies exactly when the lining is receptive for each individual patient, and uses that information to time the embryo transfer more precisely.

The ERA is a biopsy-based genetic test of the uterine lining. It is not a routine investigation — it is recommended for specific patients, primarily those who have had repeated IVF failures despite good embryo quality. This guide explains what the ERA test is, how it works, who needs it, and what to expect.

What Is the ERA Test?

ERA stands for Endometrial Receptivity Array. It is a genomic test that analyses a small sample of the uterine lining (endometrium) to determine whether the lining is in the receptive phase — the window of time during which it can accept an embryo.

In a standard IVF cycle, embryo transfer is done on a set day based on the standard hormonal protocol, assuming all patients have the same window of implantation. Research has shown this is not true. Approximately 1 in 4 women who have experienced recurrent implantation failure have a displaced window of implantation — their receptive window is earlier or later than expected.

The ERA test identifies each patient’s personalised window of implantation (pWOI) and uses it to schedule future embryo transfers at the exact right time.

💡 Key point: The ERA test does not test embryo quality. It tests only the uterine lining — specifically whether the lining is receptive (ready to receive an embryo) at the time the sample is taken.

How the ERA Test Works

The ERA test is performed during a mock (simulated) frozen embryo transfer (FET) cycle — a cycle where the patient takes the same hormonal preparation as they would for a real embryo transfer, but no embryo is transferred. Instead, a small endometrial biopsy is taken at the point where transfer would normally occur.

The Process

• The patient follows a standard FET hormonal protocol — estrogen for 10–12 days, followed by progesterone
• On the day equivalent to the planned embryo transfer day (usually Day 5 of progesterone), a thin catheter takes a small biopsy of the uterine lining
• The biopsy sample is sent to the specialist genomics laboratory
• The sample is analysed for the expression of 248 genes associated with endometrial receptivity
• Results are returned within 2–3 weeks and classify the endometrium as one of three states

ERA Result Classifications

Receptive — Standard Timing Is Correct

The lining was receptive at the standard transfer day. Proceed with embryo transfer at the standard time.

Pre-receptive — Window Opens Later

The lining was not yet receptive. The transfer is shifted forward — a later progesterone start or extended progesterone before transfer.

Post-receptive — Window Already Passed

The lining had already passed its receptive window. The transfer is shifted back — earlier in the progesterone cycle.

⚠️ Important: If the result is pre- or post-receptive, the patient repeats the mock cycle with a shifted protocol and may need a second ERA biopsy to confirm the adjusted timing before a real transfer takes place.

Who Needs the ERA Test?

The ERA test is not recommended for all IVF patients. It is a targeted investigation for specific clinical situations where standard timing has already failed.

ERA Is Recommended For

• Recurrent implantation failure — two or more failed transfers of good-quality embryos
• Recurrent IVF failure despite normal embryo quality and good endometrial thickness
• Failed transfers where all other factors (embryo, hormones, anatomy) have been ruled out
• Patients with thin endometrium or suspected endometrial issues
• Patients with unexplained infertility who have reached the embryo transfer stage

ERA Is Generally NOT Needed For

• First-time IVF cycles — standard timing works for the majority of patients
• Patients where the cause of failure is clearly embryo quality, sperm factor, or a structural issue
• Patients who have already achieved pregnancy with standard timing in a previous cycle

💡 At Javitri Hospital: ERA testing is recommended on a case-by-case basis after a thorough review of the patient’s history. Dr. Rajul Tyagi discusses whether ERA is appropriate at your consultation.

Is the ERA Test Painful?

The ERA biopsy is a minor outpatient procedure. A thin sampling catheter is passed through the cervix to take a small tissue sample from the uterine lining. Most patients describe it as similar to period cramping — brief and manageable. No anaesthesia is required in most cases.

The procedure takes a few minutes. Some patients experience mild spotting for a day or two afterwards. Normal activities resume the same day. If you are concerned about discomfort during IVF procedures generally, our guide on whether IVF is painful explains what to expect at each stage.

ERA Test Cost in India

The ERA test involves the laboratory biopsy analysis, which is performed by a specialist genomics laboratory. The cost in India typically includes the clinic consultation, the mock FET cycle hormonal protocol, the biopsy procedure, and the laboratory analysis fee.

At Javitri Hospital, the complete ERA test cost is discussed transparently at the consultation so patients can make an informed decision before proceeding. A second ERA biopsy (if the first result is non-receptive and the timing needs confirming) carries an additional laboratory cost.

💡 Note: Insurance coverage for ERA testing varies. Discuss with your insurer before the cycle. Javitri Hospital provides documentation to support insurance claims where applicable.

ERA Test vs Other Endometrial Tests

ERA is not the only test for endometrial receptivity. Here is a brief comparison to help patients understand the options.

ERA (Endometrial Receptivity Array)

Measures genomic receptivity across 248 genes. Used for recurrent implantation failure and personalised transfer timing.

EMMA (Endometrial Microbiome Metagenomic Analysis)

Measures the uterine microbiome — the balance of bacteria in the lining. Used when abnormal uterine flora is suspected alongside recurrent failure.

ALICE (Analysis of Infectious Chronic Endometritis)

Detects chronic endometritis — low-grade infection in the uterine lining. Used when endometritis is suspected, or with recurrent failure and an abnormal biopsy.

Endometrial Thickness (Ultrasound)

Measures the physical thickness of the lining in millimetres. Performed routinely in every IVF cycle as part of standard monitoring.

ERA, EMMA, and ALICE are often performed together from the same biopsy sample — called the ER Map or Trimap — as they address different aspects of endometrial health and require only one procedure.

Does the ERA Test Improve IVF Success?

The evidence for ERA is strongest in patients with recurrent implantation failure. Studies show that using ERA-guided personalised embryo transfer timing improves clinical pregnancy rates in patients who have a displaced window of implantation compared with standard timing. For patients with a receptive result on ERA, standard timing is confirmed as correct and no change is needed.

It is important to understand what ERA does and does not do. It improves the timing of transfer — it does not improve embryo quality, fix structural problems, or guarantee pregnancy. It is one piece of a larger diagnostic picture.

💡 Realistic expectation: If the ERA result is receptive, the standard protocol is confirmed — no benefit from changing timing. If the result is pre- or post-receptive, a personalised adjusted transfer significantly improves implantation chances in that patient.

When to Contact Your Clinic

• Significant cramping or heavy bleeding after the ERA biopsy procedure
• Fever above 38°C following the biopsy
• Unusual discharge after the procedure
• Any questions about your ERA result or what the recommendation means for your next transfer

⚠️ Important: If you experience heavy bleeding or fever after the ERA biopsy, contact Javitri Hospital on +91-9936068274 immediately.